Is lipoxins A4 a better alternative to anti-VEGF and anti-TNF-alpha antibody to prevent and treat age-related macular degeneration, diabetic macular edema and retinopathy?
Undurti N. Das
Med Sci Monit 2012; 18(1): LE1-2
Available online: 2011-12-22
Keywords: Macular Degeneration - prevention & control, Lipoxins - therapeutic use, Macular Edema - prevention & control, Diabetic Retinopathy - prevention & control, Antibodies - therapeutic use